Education
About Us
Working with TipRanks
Follow Us
SUSMED,Inc. (JP:4263)
:4263
4263 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥375.00 - ¥706.00
Previous CloseN/A
Volume269.90K
Average Volume (3M)54.26K
Market Cap
¥9.57B
Enterprise ValueN/A
Total Cash (Recent Filing)¥4.56B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)―
Beta0.89
Next Earnings
Aug 08, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)9.99
Shares Outstanding16,812,900
10 Day Avg. Volume64,800
30 Day Avg. Volume54,260
Financial Highlights & Ratios
PEG Ratio0.28
Price to Book (P/B)2.03
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
4263 FAQ
What was SUSMED,Inc.’s price range in the past 12 months?
SUSMED,Inc. lowest stock price was ¥375.00 and its highest was ¥706.00 in the past 12 months.
What is SUSMED,Inc.’s market cap?
SUSMED,Inc.’s market cap is ¥9.57B.
When is SUSMED,Inc.’s upcoming earnings report date?
SUSMED,Inc.’s upcoming earnings report date is Aug 08, 2025 which is in 76 days.
How were SUSMED,Inc.’s earnings last quarter?
SUSMED,Inc. released its earnings results on May 09, 2025. The company reported ¥9.99 earnings per share for the quarter, beating the consensus estimate of N/A by ¥9.99.
Is SUSMED,Inc. overvalued?
According to Wall Street analysts SUSMED,Inc.’s price is currently Overvalued.
Does SUSMED,Inc. pay dividends?
SUSMED,Inc. does not currently pay dividends.
What is SUSMED,Inc.’s EPS estimate?
SUSMED,Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SUSMED,Inc. have?
SUSMED,Inc. has 16,812,900 shares outstanding.
What happened to SUSMED,Inc.’s price movement after its last earnings report?
SUSMED,Inc. reported an EPS of ¥9.99 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.359%.
Which hedge fund is a major shareholder of SUSMED,Inc.?
Currently, no hedge funds are holding shares in JP:4263
Company Description
SUSMED,Inc.
SUSMED, Inc. develops and sells therapeutic applications in Japan. It develops smartphone based digital therapeutics applications for diseases with insomnia, breast cancer, and kidney disease. The company also develops and sells development platform for therapeutic apps and clinical trial systems. In addition, it offers medical data analysis and consulting services. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.
Technical Analysis
HOYA
―
TIS Inc.
―
Space Market, Inc.
―
JCR Pharmaceuticals Co., Ltd.
―
MedPeer, Inc.
―